The CLEAR Trial: Investigating Hypertonic Saline and Carbocisteine in Bronchiectasis
The CLEAR Trial is a 2x2 factorial randomized trial evaluating the effectiveness of hypertonic saline and carbocisteine for airway clearance in bronchiectasis over 52 weeks. Led by Professor Stuart Elborn and Professor Judy Bradley from Queen's University Belfast, the trial focuses on clinical and c
1 views • 23 slides
The CLEAR Trial: Investigating Hypertonic Saline and Carbocisteine in Bronchiectasis
The CLEAR Trial is a 2x2 factorial randomized trial examining the effectiveness of hypertonic saline and carbocisteine for airway clearance in bronchiectasis over 52 weeks. Led by Professor Stuart Elborn and Professor Judy Bradley from Queen's University Belfast, the study focuses on exacerbation ma
2 views • 16 slides
The CLEAR Trial: Investigating Hypertonic Saline and Carbocisteine for Bronchiectasis
The CLEAR Trial is a 2x2 factorial randomized trial led by Professor Stuart Elborn and Professor Judy Bradley to assess the effectiveness of hypertonic saline and carbocisteine for airway clearance in bronchiectasis patients over 52 weeks. The trial involves various study sites and potential new sit
0 views • 30 slides
The CLEAR Trial: Investigating Hypertonic Saline and Carbocisteine for Bronchiectasis Patients
The CLEAR Trial, led by Professor Stuart Elborn and Professor Judy Bradley, aims to assess the clinical and cost-effectiveness of hypertonic saline and carbocisteine for airway clearance in bronchiectasis patients over 52 weeks. The trial involves a 2x2 factorial design and various study sites acros
0 views • 23 slides
The CLEAR Trial: Investigating Hypertonic Saline and Carbocisteine for Bronchiectasis Treatment
The CLEAR Trial is a 2x2 factorial randomized trial assessing the clinical and cost-effectiveness of hypertonic saline and carbocisteine for airway clearance in bronchiectasis patients over 52 weeks. Led by Professor Stuart Elborn and Professor Judy Bradley, the trial involves randomization, sealed
0 views • 8 slides
Pharmacovigilance Guidelines for Clinical Trials in Bronchiectasis Research
The CLEAR Trial is a 2x2 factorial randomized trial evaluating the effectiveness of hypertonic saline and carbocisteine for airway clearance in bronchiectasis patients. The trial, led by Professor Stuart Elborn and Professor Judy Bradley, focuses on pharmacovigilance activities, adverse event defini
0 views • 20 slides